Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Daniel J. Berg"'
Autor:
Kellie L. Bodeker, Brian J. Smith, Daniel J. Berg, Chandrikha Chandrasekharan, Saima Sharif, Naomi Fei, Sandy Vollstedt, Heather Brown, Meghan Chandler, Amanda Lorack, Stacy McMichael, Jared Wulfekuhle, Brett A. Wagner, Garry R. Buettner, Bryan G. Allen, Joseph M. Caster, Barbara Dion, Mandana Kamgar, John M. Buatti, Joseph J. Cullen
Publikováno v:
Redox Biology, Vol 77, Iss , Pp 103375- (2024)
Background: Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have poor 5-year survival. Pharmacological ascorbate (P-AscH-, high dose, intravenous, vitamin C) has shown promise as an adjunct to chemotherapy. We hypothesized adding P-A
Externí odkaz:
https://doaj.org/article/7a718d95f6c446c69fd37ed4334b67e1
Autor:
Cameron M. Cushing, Michael S. Petronek, Kellie L. Bodeker, Sandy Vollstedt, Heather A. Brown, Emyleigh Opat, Nancy J. Hollenbeck, Thomas Shanks, Daniel J. Berg, Brian J. Smith, Mark C. Smith, Varun Monga, Muhammad Furqan, Matthew A. Howard, Jeremy D. Greenlee, Kranti A. Mapuskar, Joel St-Aubin, Ryan T. Flynn, Joseph J. Cullen, Garry R. Buettner, Douglas R. Spitz, John M. Buatti, Bryan G. Allen, Vincent A. Magnotta
Publikováno v:
Redox Biology, Vol 38, Iss , Pp 101804- (2021)
Pharmacological ascorbate (P-AscH-) combined with standard of care (SOC) radiation and temozolomide is being evaluated in a phase 2 clinical trial (NCT02344355) in the treatment of glioblastoma (GBM). Previously published data demonstrated that param
Externí odkaz:
https://doaj.org/article/ab946eefd1804c1cbcca282d6397675a
Autor:
Steven N. Seyedin, Margaret K. Gannon, Kristin A. Plichta, Laith Abushahin, Daniel J. Berg, Evgeny V. Arshava, Kalpaj R. Parekh, John C. Keech, Joseph M. Caster, James W. Welsh, Bryan G. Allen
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: This study aimed to investigate the feasibility of stereotactic body radiation therapy (SBRT) as salvage therapy for locally recurrent esophageal cancer. We hypothesized that SBRT would provide durable treated tumor control with minimal asso
Externí odkaz:
https://doaj.org/article/39f9f79939cf4e42bb7142898f2b1c6f
Autor:
Kristin E. Brandt, Kelly C. Falls, Joshua D. Schoenfeld, Samuel N. Rodman, Zhimin Gu, Fenghuang Zhan, Joseph J. Cullen, Brett A. Wagner, Garry R. Buettner, Bryan G. Allen, Daniel J. Berg, Douglas R. Spitz, Melissa A. Fath
Publikováno v:
Redox Biology, Vol 14, Iss , Pp 82-87 (2018)
Pharmacological doses (> 1Â mM) of ascorbate (a.k.a., vitamin C) have been shown to selectively kill cancer cells through a mechanism that is dependent on the generation of H2O2 at doses that are safely achievable in humans using intravenous adminis
Externí odkaz:
https://doaj.org/article/959fae2b285c4504aa4c9bdc7bfe028d
Autor:
Joseph J. Cullen, Bryan G. Allen, Heather A. Brown, Sandy Vollstedt, Kellie L. Bodeker, Daniel J. Berg, John M. Buatti, Douglas R. Spitz, Brianne R. O’Leary, Katherine Gibson-Corley, Juan Du, Brett A. Wagner, Garry R. Buettner, Samuel R. Schroeder, Justin G. Wilkes, Matthew S. Alexander
Radiation induced intestinal damage histology and collagen deposition information.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007e7e320ffa5f1cd07d7839b75a3af6
https://doi.org/10.1158/0008-5472.22420140
https://doi.org/10.1158/0008-5472.22420140
Autor:
Joseph J. Cullen, Bryan G. Allen, Heather A. Brown, Sandy Vollstedt, Kellie L. Bodeker, Daniel J. Berg, John M. Buatti, Douglas R. Spitz, Brianne R. O’Leary, Katherine Gibson-Corley, Juan Du, Brett A. Wagner, Garry R. Buettner, Samuel R. Schroeder, Justin G. Wilkes, Matthew S. Alexander
The effect of ascorbate and catalase on clonogenic cell survival in PDAC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f06878d41c887f75876ffc980c62e2b
https://doi.org/10.1158/0008-5472.22420149
https://doi.org/10.1158/0008-5472.22420149
Autor:
Joseph J. Cullen, Bryan G. Allen, Heather A. Brown, Sandy Vollstedt, Kellie L. Bodeker, Daniel J. Berg, John M. Buatti, Douglas R. Spitz, Brianne R. O’Leary, Katherine Gibson-Corley, Juan Du, Brett A. Wagner, Garry R. Buettner, Samuel R. Schroeder, Justin G. Wilkes, Matthew S. Alexander
Chemoradiation therapy is the mainstay for treatment of locally advanced, borderline resectable pancreatic cancer. Pharmacologic ascorbate (P-AscH−, i.e., intravenous infusions of ascorbic acid, vitamin C), but not oral ascorbate, produces high pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa25ab339c827584a92b1e81f77dd312
https://doi.org/10.1158/0008-5472.c.6510567.v1
https://doi.org/10.1158/0008-5472.c.6510567.v1
Autor:
Michael Pishvaian, Amer Zureikat, Charles Lopez, Kenneth Meredith, Emmanuel Zervos, Hassan Hatoum, Ki Chung, Daniel J. Berg, Antonio Ucar, Ripal Gandhi, Reza Nazemzadeh, Parikh Nainesh, Paula Novelli, Brian Kouri, Christopher Laing, Brian Boone, Thor Johnson, Susan Bates, Karyn Goodman, Ramtin Agah
Publikováno v:
Cancer Research. 83:CT084-CT084
Background: Treatment of locally advanced pancreatic cancer (LAPC) remains a clinical challenge with a median survival of 16-18 months1. Control of local disease, beyond systemic therapy, is part of the treatment paradigm being investigated in this p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd948d96b1c030d8df29a3e9321ac83d
https://doi.org/10.1158/1538-7445.am2023-ct084
https://doi.org/10.1158/1538-7445.am2023-ct084
Autor:
Matan Geron, Adrien Tassou, Daniel J. Berg, Andrew Shuster, Lee-Yuan Liu-Chen, Grégory Scherrer
Publikováno v:
The Journal of Pain. 24:36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0588fb10a7863d6d7390c0717fb91577
https://doi.org/10.1016/j.jpain.2023.02.114
https://doi.org/10.1016/j.jpain.2023.02.114
Autor:
Daniel J. Berg, Jermaine Coward, Kathleen N. Moore, Paul R. Harnett, James Garner, Ganessan Kichenadasse, Don S. Dizon, Minal A. Barve
Publikováno v:
Cancers, Vol 13, Iss 3196, p 3196 (2021)
Cancers
Volume 13
Issue 13
Cancers
Volume 13
Issue 13
Survival outcomes in ovarian cancer are poor. The aims of this Phase I progressive design study (NCT02903771) were to evaluate the maximum tolerated dose (MTD), tolerability, and antitumor activity of Cantrixil—a novel third-generation benzopyran m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adcdc035911409e8d231f8fbd3b621fd
https://www.mdpi.com/2072-6694/13/13/3196
https://www.mdpi.com/2072-6694/13/13/3196